NSW Health pays the patient co-payment for some prescriptions under section 100 of the National Health Act 1953 for eligible patients. This includes medicines listed on the
PBS under the s100 Highly Specialised Drugs (HSD) Program Public Hospital schedule, s100 HSD Community Access schedule (for HIV, Hepatitis B, and clozapine maintenance therapy medicines), and injectable and infusible chemotherapy medicines on the PBS s100 Efficient Funding for Chemotherapy (Public Hospital) schedule.
Patients are eligible for the co-payment for s100 medicines if they meet the eligibility criteria and provide consent.
All of the following eligibility criteria must be met for the co-payment to be paid by NSW Health.
More information about authorised community prescribers is found on
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine. For clozapine, prescribers and patients must meet the
PBS eligibility requirements.
Eligible patients need to provide consent for NSW Health to make s100 co-payments on their behalf. The process varies according to patient prescription, as follows:
Existing 12 Month Patient Consent Forms remain valid until the renewal period expires. Consent forms that require renewal after 1 January 2023 should use the 3 Year Patient Consent Form.
NSW s100 co-payment enquires can be emailed to:
For more information on how NSW Health manages your personal information visit